1. |
- Kordatzaki, G., et al.
(författare)
-
A diachronic investigation of 'local' pottery production and supply at the sanctuary of Zeus, Mount Lykaion, Arcadia, Peloponnese
- 2016
-
Ingår i: Journal of Archaeological Science: Reports. - : Elsevier BV. - 2352-409X .- 2352-4103. ; 7, s. 526-529
-
Tidskriftsartikel (refereegranskat)abstract
- © 2016 Elsevier Ltd. The present paper reports results of an integrated study of a selection of pottery recovered from the altar of Zeus, Mount Lykaion, Arcadia, in the Peloponnese, Greece, dating from the Neolithic to the Early Iron Age. A multi-analytical approach based on petrographic and chemical analysis, supported by refiring tests and geological sampling, has been employed to tackle issues of technology and provenance. Results shed light on patterns of raw material sources exploitation and pottery production and supply at the site over time.
|
|
2. |
|
|
3. |
- Andersson, E., et al.
(författare)
-
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
- 2018
-
Ingår i: AIDS. - 0269-9370. ; 32:7, s. 877-884
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To study the trends of transmitted drug resistance (TDR) in HIV-1 patients newly diagnosed in Sweden, 2010-2016. Design: Register-based study including all antiretroviral therapy-naive patients ≥18 years diagnosed with HIV-1 in Sweden 2010-2016. Methods: Patient data and viral pol sequences were extracted from the national InfCareHIV database. TDR was defined as the presence of surveillance drug resistance mutations (SDRMs). A CD4+ T-cell decline trajectory model estimated time of infection. Phylogenetic inference was used for cluster analysis. Chi-square tests and logistic regressions were used to investigate relations between TDR, epidemiological and viral factors. Results: One thousand, seven hundred and thirteen pol sequences were analyzed, corresponding to 71% of patients with a new HIV-1 diagnosis (heterosexuals: 53%; MSM: 34%). The overall prevalence of TDR was 7.1% (95% CI 5.8-8.3%). Nonnucleoside reverse transcriptase inhibitor (NNRTI) TDR increased significantly from 1.5% in 2010 to 6.2% in 2016, and was associated to infection and/or origin in sub-Saharan Africa (SSA). An MSM transmission cluster dating back to the 1990s with the M41L SDRM was identified. Twenty-five (1.5%) patients exhibited TDR to tenofovir (TDF; n = 8), emtricitabine/lamivudine (n = 9) or both (n = 8). Conclusion: NNRTI TDR has increased from 2010 to 2016 in HIV-1-infected migrants from SSA diagnosed in Sweden, mirroring the situation in SSA. TDR to tenofovir/emtricitabine, used in preexposure prophylaxis, confirms the clinical and epidemiological need for resistance testing in newly diagnosed patients.
|
|
4. |
- Carlsson, Axel C, et al.
(författare)
-
Soluble tumor necrosis factor receptor 1 is associated with glomerular filtration rate progression and incidence of chronic kidney disease in two community-based cohorts of elderly individuals
- 2015
-
Ingår i: CardioRenal Medicine. - : S. Karger AG. - 1664-3828 .- 1664-5502. ; 5:4, s. 278-288
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: We aimed to explore and validate the longitudinal associations between soluble tumor necrosis factor receptor 1 (sTNFR1), glomerular filtration rate (GFR) progression, and chronic kidney disease (CKD) incidence in two independent community-based cohorts of elderly individuals with prespecified subgroup analyses in individuals without prevalent diabetes.Research design and methods: Two community-based cohorts of elderly individuals were used with 5-year follow-up data on estimated GFR: the Uppsala Longitudinal Study of Adult Men (ULSAM; n = 437 men; mean age: 78 years) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n = 703; mean age: 70 years; 51% women). GFR categories were defined as >= 60, 30-60, and <30 ml/min/1.73 m(2).Results: In longitudinal multivariable logistic regression models adjusted for inflammatory markers and established cardiovascular risk factors, higher serum sTNFR1 was significantly associated with an increased risk to progress to a lower GFR category in both ULSAM and PIVUS [odds ratio (OR) per standard deviation (SD) increase 1.28 (95% CI 1.03-1.60) and OR 1.56 (95% CI 1.30-1.87), respectively]. Also, in subgroup analyses in individuals with a GFR >= 60 ml/min/1.73 m(2) at baseline, higher sTNFRs were associated with incident CKD after 5 years in both cohorts [ULSAM: OR per SD increase 1.49 (95% CI 1.16-1.9) and PIVUS: OR 1.84 (95% CI 1.50-2.26)]. Associations were similar in individuals without diabetes.Conclusions: Higher circulating sTNFR1 independently predicts the progression to a worse GFR category and CKD incidence in elderly individuals even in the absence of diabetes. Further studies are warranted to investigate the underlying mechanisms, and to evaluate the clinical relevance of our findings.
|
|
5. |
|
|
6. |
- Nordquist, Margaretha, 1972-
(författare)
-
A Struggle for the Realm : Late-medieval Swedish rhyme chronicles as ideological expressions
- 2015
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The period from the mid-fifteenth century to the early sixteenth century was characterised by recurrent political turmoil and conflict in Scandinavia in general, and in Sweden in particular. Political power was contested, not least because of the disputed conditions on which the Swedish realm should be governed as part of the Scandinavian union monarchy. Contenders for power based their claims on support from various factions of the ecclesiastical and secular aristocracy. Other groups within the realm played a crucial role as allies, supporters or armed levies.In A Struggle for the Realm, Margaretha Nordquist examines the late-medieval Swedish rhyme chronicles Sturekrönikan (c. 1496–1497) and Cronica Swecie (c. 1520–1523) as ideological responses to contemporary conflicts of power. The rhyme chronicles describe some of the key events and actors in the period, in ways that both differ and overlap. As partisan narratives written in support of particular political factions, the rhyme chronicles can be seen as verbal contributions in a struggle for the realm. Nordquist's analysis shows that the realm functioned as a fundamental ideological construct in the chronicles. The realm and the Swedish community were key mobilising elements in the efforts to legitimate and consolidate certain positions of power, but the precise meaning and implications of the Swedish realm and the Swedish community were not fixed. The community of Swedes is primarily envisioned as a political and social entity, although the common, ancient origin of the people is an important element in Cronica Swecie. The concept of regnal ideology is used to describe the creation of ideological meaning in the rhyme chronicles. While the realm possesses substantial ideological validity in both chronicles, they differ in the particular configuration of power they advocate as a basis for the government of the realm.
|
|
7. |
- Sartor, O., et al.
(författare)
-
Re-treatment with radium-223 : first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases
- 2017
-
Ingår i: Annals of Oncology. - : OXFORD UNIV PRESS. - 0923-7534 .- 1569-8041. ; 28:10, s. 2464-2471
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Six radium-223 injections at 4-week intervals is indicated for patients with castration-resistant prostate cancer and symptomatic bone metastases. However, patients usually develop disease progression after initial treatment. This prospective phase I/II study assessed re-treatment safety and efficacy of up to six additional radium-223 injections. Patients and methods: Patients had castration-resistant prostate cancer and bone metastases and six initial radium-223 injections with no on-treatment bone progression; all had subsequent radiologic or clinical progression. Concomitant agents were allowed at investigator discretion, excluding chemotherapy and initiation of new abiraterone or enzalutamide. The primary endpoint was safety; additional exploratory endpoints included time to radiographic bone progression, time to total alkaline phosphatase and prostate-specific antigen progression, radiographic progression-free survival, overall survival, time to first symptomatic skeletal event (SSE), SSE-free survival, and time to pain progression. Results: Among 44 patients, 29 (66%) received all six re-treatment injections. Median time from end of initial radium-223 treatment was 6 months. Forty-one (93%) reported >= 1 treatment-emergent adverse event. No grade 4-5 hematologic treatment-emergent adverse events occurred. Only one (2%) patient had radiographic bone progression; eight (18%) had radiographic soft tissue tumor progression (three lymph node and five visceral metastases). Median times to total alkaline phosphatase and prostate-specific antigen progression were not reached and 2.2 months, respectively. Median radiographic progression-free survival was 9.9 months (12.8-month maximum follow-up). Five (11%) patients died and eight (18%) experienced first SSEs. Median overall survival, time to first SSE, and SSE-free survival were not reached. Five (14%) of 36 evaluable patients (baseline worst pain score <= 7) had pain progression. After 2 years of follow-up, 28 (64%) patients died, and the median overall survival was 24.4 months. Conclusions: Re-treatment with a second course of six radium-223 injections after disease progression is well tolerated, with minimal hematologic toxicity and low radiographic bone progression rates in this small study with limited follow-up. Favorable safety and early effects on disease progression indicate that radium-223 re-treatment is feasible and warrants further evaluation in larger prospective trials.
|
|
8. |
|
|